17β-estradiol induces vasorelaxation by stimulating endothelial hydrogen sulfide release

Molecular Human Reproduction

Volumn 19, Issue 3, 2013, Pages 169-176

  Zhou, Kewen ^a   Gao, Qi ^a   Zheng, Shuhui ^b   Pan, Sinian ^c   Li, Ping ^a   Suo, Kun ^d   Simoncini, Tommaso ^e   Wang, Tinghuai ^a   Fu, Xiaodong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^e UNIVERSITY OF PISA   (Italy)

Author keywords

17 estradiol; Atherosclerosis; Hydrogen sulfide; Vascular endothelial cells; Vasorelaxation

Indexed keywords

1,3,5 TRIS(4 HYDROXYPHENYL) 4 PROPYLPYRAZOLE; ACETYLCHOLINE; APOLIPOPROTEIN E; CYCLIC GMP DEPENDENT PROTEIN KINASE; ESTRADIOL; HYDROGEN SULFIDE; KT 5823; NITRIC OXIDE; PLACEBO; PROPARGYLGLYCINE; PROSTACYCLIN;

ANIMAL EXPERIMENT; AORTA ATHEROSCLEROSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FEMORAL ARTERY; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; UMBILICAL VEIN ENDOTHELIAL CELL; VASODILATATION;

ACETYLCHOLINE; ALKYNES; ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CYCLIC GMP-DEPENDENT PROTEIN KINASES; CYSTATHIONINE GAMMA-LYASE; DELAYED-ACTION PREPARATIONS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; GLYCINE; HYDROGEN SULFIDE; MICE; MICE, KNOCKOUT; OVARIECTOMY; PLAQUE, ATHEROSCLEROTIC; PROTEIN KINASE INHIBITORS; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; VASODILATION;

MUS;

EID: 84876486274     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gas044     Document Type: Article

References (45)

1. Bae YH, Ding Z, Zou L, Wells A, Gertler F, Roy P. Loss of profilin-1 expression enhances breast cancer cell motility by Ena/VASP proteins. J Cell Physiol 2009;219:354-364.
2. Billon-Gales A, Fontaine C, Douin-Echinard V, Delpy L, Berges H, Calippe B, Lenfant F, Laurell H, Guery JC, Gourdy P et al. Endothelial estrogen receptor α plays a crucial role in the atheroprotective action of 17β-estradiol in low-density lipoprotein receptor-deficient mice. Circulation 2009;120:2567-2576.
3. Bourassa PA, Milos PM, Gaynor BJ, Breslow JL, Aiello RJ. Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. Proc Natl Acad Sci USA 1996;93:10022-7.
4. Burger NZ, Kuzina OY, Osol G, Gokina NI. Estrogen replacement enhances EDHF-mediated vasodilation of mesenteric and uterine resistance arteries: role of endothelial cell Ca2+. Am J Physiol Endocrinol Metab 2009;296:E503-E512.
5. Burley DS, Ferdinandy P, Baxter GF. Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling. Br J Pharmacol 2007;152:855-869.
6. Chakrabarti S, Lekontseva O, Peters A, Davidge ST. 17β-Estradiol induces protein S-nitrosylation in the endothelium. Cardiovasc Res 2010; 85:796-805.
7. Chambliss KL, Shaul PW. Estrogen modulation of endothelial nitric oxide synthase. Endocr Rev 2002;23:665-686.
8. Coletta C, Papapetropoulos A, Erdelyi K, Olah G, Modis K, Panopoulos P, Asimakopoulou A, Gero D, Sharina I, Martin E et al. Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation. Proc Natl Acad Sci USA 2012;109:9161-9166.
9. Filipe C, Lam Shang Leen L, Brouchet L, Billon A, Benouaich V, Fontaine V, Gourdy P, Lenfant F, Arnal JF, Gadeau AP et al. Estradiol accelerates endothelial healing through the retrograde commitment of uninjured endothelium. Am J Physiol Heart Circ Physiol 2008;294:H2822-H2830.
10. Fu XD, Simoncini T. Extra-nuclear signaling of estrogen receptors. IUBMB Life 2008;60:502-510.
11. Haynes MP, Sinha D, Russell KS, Collinge M, Fulton D, Morales-Ruiz M, Sessa WC, Bender JR. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res 2000;87:677-682.
12. Hodgin JB, Knowles JW, Kim HS, Smithies O, Maeda N. Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice. J Clin Invest 2002;109:541-548.
13. Hodis HN, Mack WJ, Lobo RA, Shoupe D, Sevanian A, Mahrer PR, Selzer RH, Liu Cr CR, Liu Ch CH, Azen SP. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001;135:939-953.
14. Keung W, Chan ML, Ho EY, Vanhoutte PM, Man RY. Non-genomic activation of adenylyl cyclase and protein kinase G by 17β-estradiol in vascular smooth muscle of the rat superior mesenteric artery. Pharmacol Res 2011;64:509-516.
15. Kublickiene K, Fu XD, Svedas E, Landgren BM, Genazzani AR, Simoncini T. Effects in postmenopausal women of estradiol and medroxyprogesterone alone and combined on resistance artery function and endothelial morphology and movement. J Clin Endocrinol Metab 2008;93:1874-1883.
16. Levin ER. Plasma membrane estrogen receptors. Trends Endocrinol Metab 2009;20:477-482.
17. Lima SM, Aldrighi JM, Consolim-Colombo FM, Mansur Ade P, Rubira MC, Krieger EM, Ramires JA. Acute administration of 17β-estradiol improves endothelium-dependent vasodilation in postmenopausal women. Maturitas 2005;50:266-274.
18. Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science 2005;308:1583-1587.
19. Miller VM, Duckles SP. Vascular actions of estrogens: functional implications. Pharmacol Rev 2008;60:210-241.
20. Pan LL, Liu XH, Gong QH, Yang HB, Zhu YZ. Role of cystathionine γ-lyase/hydrogen sulfide pathway in cardiovascular disease: a novel therapeutic strategy? Antioxid Redox Signal 2012;17:106-118.
21. Papapetropoulos A, Pyriochou A, Altaany Z, Yang G, Marazioti A, Zhou Z, Jeschke MG, Branski LK, Herndon DN, Wang R et al. Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci USA 2009;106:21972-7.
22. Rayner K, Sun J, Chen YX, McNulty M, Simard T, Zhao X, Wells DJ, de Belleroche J, O'Brien ER. Heat shock protein 27 protects against atherogenesis via an estrogen-dependent mechanism: role of selective estrogen receptor β modulation. Arterioscler Thromb Vasc Biol 2009; 29:1751-1756.
23. Russell KS, Haynes MP, Sinha D, Clerisme E, Bender JR. Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc Natl Acad Sci USA 2000; 97:5930-5935.
24. Salloum FN, Chau VQ, Hoke NN, Abbate A, Varma A, Ockaili RA, Toldo S, Kukreja RC. Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia/reperfusion through protein-kinase G-dependent generation of hydrogen sulfide. Circulation 2009;120:S31-S36.
25. Scotland RS, Madhani M, Chauhan S, Moncada S, Andresen J, Nilsson H, Hobbs AJ, Ahluwalia A. Investigation of vascular responses in endothelial nitric oxide synthase/cyclooxygenase-1 double-knockout mice: key role for endothelium-derived hyperpolarizing factor in the regulation of blood pressure in vivo. Circulation 2005;111:796-803.
26. Seo HS, Lombardi DM, Polinsky P, Powell-Braxton L, Bunting S, Schwartz SM, Rosenfeld ME. Peripheral vascular stenosis in apolipoprotein E-deficient mice. Potential roles of lipid deposition, medial atrophy, and adventitial inflammation. Arterioscler Thromb Vasc Biol 1997;17:3593-3601.
27. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 2000;407:538-541.
28. Simoncini T, Scorticati C, Mannella P, Fadiel A, Giretti MS, Fu XD, Baldacci C, Garibaldi S, Caruso A, Fornari L et al. Estrogen receptor α interacts with Gα13 to drive actin remodeling and endothelial cell migration via the RhoA/Rho kinase/moesin pathway. Mol Endocrinol 2006;20:1756-1771.
29. Sobrino A, Oviedo PJ, Novella S, Laguna-Fernandez A, Bueno C, Garcia-Perez MA, Tarin JJ, Cano A, Hermenegildo C. Estradiol selectively stimulates endothelial prostacyclin production through estrogen receptor α. J Mol Endocrinol 2010;44:237-246.
30. Suzuki K, Olah G, Modis K, Coletta C, Kulp G, Gero D, Szoleczky P, Chang T, Zhou Z, Wu L et al. Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function. Proc Natl Acad Sci USA 2011;108:13829-13834.
31. Szabo C. Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 2007;6:917-935.
32. Thompson GA, Datko AH, Mudd SH. Methionine synthesis in Lemna: inhibition of cystathionine γ-synthase by propargylglycine. Plant Physiol 1982;70:1347-1352.
33. Torii R, Shiomi M, Ito T, Yamada S, Eguchi Y, Ikeda N. Cholesterol-fed ovariectomized monkeys are good animal models for human atherosclerosis of postmenopausal women. Primates 2003;44:247-252.
34. Vanhoutte PM, Shimokawa H, Tang EH, Feletou M. Endothelial dysfunction and vascular disease. Acta Physiol 2009;196:193-222.
35. Villar IC, Francis S, Webb A, Hobbs AJ, Ahluwalia A. Novel aspects of endothelium-dependent regulation of vascular tone. Kidney Int 2006; 70:840-853.
36. Wang R. Hydrogen sulfide: a new EDRF. Kidney Int 2009;76:700-704.
37. Wang Y, Zhao X, Jin H, Wei H, LiW, Bu D, Tang X, Ren Y, Tang C, Du J. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2009; 29:173-179.
38. White RE, Darkow DJ, Lang JL. Estrogen relaxes coronary arteries by opening BKCa channels through a cGMP-dependent mechanism. Circ Res 1995;77:936-942.
39. Williams JK, Adams MR, Herrington DM, Clarkson TB. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol 1992;20:452-457.
40. Xiang Q, Lin G, Fu X, Wang S, Wang T. The role of peroxisome proliferator-activated receptor-g and estrogen receptors in genistein-induced regulation of vascular tone in female rat aortas. Pharmacology 2010;86:117-124.
41. Xing D, Nozell S, Chen YF, Hage F, Oparil S. Estrogen and mechanisms of vascular protection. Arterioscler Thromb Vasc Biol 2009;29:289-295.
42. 2S on human aorta smooth muscle cells. FASEB J 2006;20:553-555.
43. 2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine γ-lyase. Science 2008;322:587-590.
44. Yang G, Pei Y, Teng H, Cao Q, Wang R. Specificity protein-1 as a critical regulator of human cystathionine γ-lyase in smooth muscle cells. J Biol Chem 2011;286:26450-26460.
45. Zheng S, Huang J, Zhou K, Zhang C, Xiang Q, Tan Z, Wang T, Fu X. 17β-Estradiol enhances breast cancer cell motility and invasion via extra-nuclear activation of actin-binding protein ezrin. PLoS One 2011; 6:e22439.